| 1 | Changes in neuroinflammatory markers and microglial density in the hippocampus and prefrontal cortex of the C58/J mouse model of autism | Coautor: Velasco Velázquez M.A., Duarte-Campos J.F., Vázquez-Moreno C.N., Martínez-Marcial M., et al. | 2024 | EUROPEAN JOURNAL OF NEUROSCIENCE | WoS-id: 001114346500001
Scopus-id: 2-s2.0-85178901873
| 3 | 2 |
| 2 | The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer | Coautor: Velasco-Velázquez M.A., De La Cruz-Sigüenza D.A., Reyes-Grajeda J.P., Trejo-Becerril C., et al. | 2024 | MOLECULAR BIOLOGY REPORTS | WoS-id: 001147955900008
Scopus-id: 2-s2.0-85182846959
| 0 | 0 |
| 3 | Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning | Coautor: Velasco-Velázquez M.A., Juárez-Mercado K.E., Gómez-Hernández M.A., Salinas-Trujano J., et al. | 2024 | Pharmaceuticals | WoS-id: 001177107600001
Scopus-id: 2-s2.0-85186745539
| 1 | 2 |
| 4 | Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 Mpro Inhibitors from Large Chemical Libraries | Coautor: Velasco-Velázquez M.A., Ruiz-Moreno A.J., Cedillo-González R., Cordova-Bahena L., et al. | 2024 | JOURNAL OF CHEMICAL INFORMATION AND MODELING | WoS-id: 001184846200001
Scopus-id: 2-s2.0-85187651671
| 0 | 0 |
| 5 | Continuous exposure to doxorubicin induces stem cell-like characteristics and plasticity in MDA-MB-231 breast cancer cells identified with the SORE6 reporter | Coautor: Velasco-Velazquez, MA, Salinas-Jazmin, N, Medina-Mondragon, MA, Jimenez-Lopez, J, et al. | 2024 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | WoS-id: 001297576200002
Scopus-id: 2-s2.0-85201963833
| 0 | 0 |
| 6 | Agave mapisaga aqueous extract shows in vitro and in vivo activity on murine prostate cancer cells | Coautor: Velasco-Velazquez, Marco A., Hernandez-Peralta, Pablo, Garcia-Espejo, David A., Gracia-Mora, I, Maria, et al. | 2023 | BOLETIN LATINOAMERICANO Y DEL CARIBE DE PLANTAS MEDICINALES Y AROMATICAS | WoS-id: 000863020000003
Scopus-id: 2-s2.0-85137605484
| 0 | 1 |
| 7 | Neuroprotective Agents with Therapeutic Potential for COVID-19 | Coautor: Velasco-Velázquez M.A., Zaa C.A., Espitia C., Reyes-Barrera K.L., et al. | 2023 | Biomolecules | WoS-id: 001107843500001
Scopus-id: 2-s2.0-85177765496
| 3 | 3 |
| 8 | Anthocyanins: Molecular Aspects on Their Neuroprotective Activity | Coautor: Velasco-Velázquez M.A., Zaa C.A., Marcelo Á.J., An Z., et al. | 2023 | Biomolecules | WoS-id: 001107989900001
Scopus-id: 2-s2.0-85177780590
| 14 | 12 |
| 9 | Repositioning of etravirine as a potential CK1e inhibitor by virtual screening | Coautor: Velasco-Velazquez, Marco A., Cordova-Bahena, Luis, Sanchez-Alvarez, Axel A., Ruiz-Moreno, Angel J. | 2022 | Pharmaceuticals | WoS-id: 000747901100001
Scopus-id: 2-s2.0-85121660036
| 1 | 2 |
| 10 | High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma | Coautor: Velasco-Velazquez, Marco, Sanchez-Ramirez, Damian, Medrano-Guzman, Rafael, Candanedo-Gonzalez, Fernando, et al. | 2022 | EUROPEAN JOURNAL OF HISTOCHEMISTRY | WoS-id: 000778915700005
Scopus-id: 2-s2.0-85124777663
| 4 | 4 |
| 11 | Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein | Coautor: Velasco-Velazquez, Marco A., Sadremomtaz, Afsaneh, Al-Dahmani, Zayana M., Ruiz-Moreno, Angel J., et al. | 2022 | JOURNAL OF MEDICINAL CHEMISTRY | WoS-id: 000797940600009
Scopus-id: 2-s2.0-85113704844
| 21 | 23 |
| 12 | The interplay between estrogen receptor beta and protein kinase C, a crucial collaboration for medulloblastoma cell proliferation and invasion | Coautor: Velasco-Velazquez, Marco A., Hernandez-Rojas, Rubi, Jimenez-Arellano, Carolina, de la Fuente-Granada M., et al. | 2022 | CELLULAR SIGNALLING | WoS-id: 000798851100006
Scopus-id: 2-s2.0-85123179098
| 5 | 4 |
| 13 | DRD1 and DRD4 are differentially expressed in breast tumors and breast cancer stem cells: pharmacological implications | Coautor: Velasco-Velázquez M.A., Rosas-Cruz A., Salinas-Jazmín N., Valdés-Rives A. | 2022 | TRANSLATIONAL CANCER RESEARCH | WoS-id: 000879997800001
Scopus-id: 2-s2.0-85147683325
| 1 | 0 |
| 14 | Role of CD36 in cancer progression, stemness, and targeting | Coautor: Velasco-Velazquez, Marco A., Guerrero-Rodriguez, Sandra L., Mata-Cruz, Cecilia, Perez-Tapia, Sonia M. | 2022 | Frontiers In Cell And Developmental Biology | WoS-id: 000902067500001
Scopus-id: 2-s2.0-85144537059
| 24 | 28 |
| 15 | Bioassays for the Evaluation of Target Neutralization and Complement-Dependent Cytotoxicity (CDC) of Therapeutic Antibodies | Coautor y autor de correspondencia: Velasco-Velázquez M.A., Salinas-Jazmín N., Medina-Rivero E. | 2022 | Methods in Molecular Biology | Scopus-id: 2-s2.0-85114618359
| 0 | 2 |
| 16 | Quality attributes of partially hydrolyzed collagen in a liquid formulation used for skin care | Coautor: Velasco-Velázquez M., Mejía-Calvo I., López-Juárez L.E., Vázquez-Leyva S., et al. | 2021 | JOURNAL OF COSMETIC DERMATOLOGY | WoS-id: 000531259100001
Scopus-id: 2-s2.0-85084512319
| 4 | 4 |
| 17 | Repurposing the HCV NS3-4A protease drug boceprevir as COVID-19 therapeutics | Coautor: Velasco-Velazquez, Marco A., Oerlemans, Rick, Ruiz-Moreno, Angel Jonathan, Cong, Yingying, et al. | 2021 | Rsc Medicinal Chemistry | WoS-id: 000635760100004
Scopus-id: 2-s2.0-85103508344
| 60 | 60 |
| 18 | In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates | Coautor: Velasco-Velazquez, Marco A., Ruiz-Moreno, Angel J., Reyes-Romero, Atilio, Dömling A. | 2021 | Molecules | WoS-id: 000638725800001
Scopus-id: 2-s2.0-85103919519
| 5 | 6 |
| 19 | Progesterone Receptor Together with PKC alpha Expression as Prognostic Factors for Astrocytomas Malignancy | Coautor: Velasco-Velazquez, Marco A., Arcos-Montoya, Denisse, Wegman-Ostrosky, Talia, Mejia-Perez, Sonia, et al. | 2021 | ONCOTARGETS AND THERAPY | WoS-id: 000662119300001
Scopus-id: 2-s2.0-85115895332
| 5 | 6 |
| 20 | ANTI-PD-1 AND ANTI-PD-L1 ANTIBODIES AS IMMUNOTHERAPY AGAINST CANCER: A STRUCTURAL PERSPECTIVE | 2ᵒ autor y autor de correspondencia: Velasco-Velazquez, Marco A., Cordova-Bahena, Luis | 2021 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000662706100003
Scopus-id: 2-s2.0-85102090743
| 13 | 12 |
| 21 | Erratum: Benchmark of Generic Shapes for Macrocycles (Journal Chemical Information Modeling (2020) 60:12 (6298-6313) DOI: 10.1021/acs.jcim.0c01038) | Coautor: Velasco-Velázquez M., Reyes Romero A., Ruiz-Moreno A.J., Groves M.R., et al. | 2021 | JOURNAL OF CHEMICAL INFORMATION AND MODELING | WoS-id: 000669541400056
Scopus-id: 2-s2.0-85108123009
| 0 | 0 |
| 22 | Reporter gene systems for the identification and characterization of cancer stem cells | Coautor y autor de correspondencia: Velasco-Velazquez, Marco, Salinas-Jazmin, Nohemi, Rosas-Cruz, Arely | 2021 | World Journal of Stem Cells | WoS-id: 000679408700009
Scopus-id: 2-s2.0-85111729027
| 3 | 4 |
| 23 | Reverse Docking for the Identification of Molecular Targets of Anticancer Compounds | Coautor y autor de correspondencia: Velasco-Velázquez M.A., Ruiz-Moreno A.J., Dömling A. | 2021 | Methods in Molecular Biology | WoS-id: 000684295200005
Scopus-id: 2-s2.0-85090237607
| 6 | 6 |
| 24 | Dopamine Receptors in Cancer: Are They Valid Therapeutic Targets? | Coautor y autor de correspondencia: Velázquez M.A.V., Rosas-Cruz, Arely, Salinas-Jazmin, Nohemi | 2021 | TECHNOLOGY IN CANCER RESEARCH & TREATMENT | WoS-id: 000688089000001
Scopus-id: 2-s2.0-85110392301
| 22 | 21 |
| 25 | Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile | Coautor: Velasco-Velazquez, Marco, Perdomo-Abundez, Francisco C., Vallejo-Castillo, Luis, Vazquez-Leyva, Said, et al. | 2020 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | WoS-id: 000515445300007
Scopus-id: 2-s2.0-85076535901
| 8 | 8 |
| 26 | Pranlukast Antagonizes CD49f and Reduces Sternness in Triple-Negative Breast Cancer Cells | Coautor: Velasco-Velazquez, Marco A., Velazquez-Quesada, Ines, Ruiz-Moreno, Angel J., Casique-Aguirre, Diana, et al. | 2020 | DRUG DESIGN DEVELOPMENT AND THERAPY | WoS-id: 000532319300001
Scopus-id: 2-s2.0-85085103965
| 6 | 6 |
| 27 | Transferon (R) in 2020 | Coautor: Velasco-Velazquez, M. A., Perez-Tapia, S. M., Vallejo-Castillo, L., Lopez-Morales, C. A., et al. | 2020 | Revista Bio Ciencias | WoS-id: 000579342700029
| 0 | 0 |
| 28 | Anticuerpos conjugados a fármaco: la nueva generación de terapias biotecnológicas contra el cáncer | Coautor: Velasco-Velazquez, Marco A., Melgarejo-Rubio, Guadalupe, Perez-Tapia, Sonia M., Medina-Rivero, Emilio | 2020 | GACETA MEDICA DE MEXICO | WoS-id: 000581073500009
Scopus-id: 2-s2.0-85086531398
| 4 | 4 |
| 29 | Scaffolding-Induced Property Modulation of Chemical Space | Coautor: Velasco-Velazquez, Marco A., Li, Jingyao, Di Lorenzo, Vincenzo, Patil, Pravin, et al. | 2020 | ACS COMBINATORIAL SCIENCE | WoS-id: 000607536400005
Scopus-id: 2-s2.0-85088205549
| 5 | 7 |
| 30 | Benchmark of Generic Shapes for Macrocycles | Coautor: Velasco-Velázquez M., Reyes Romero A., Ruiz-Moreno A.J., Groves M.R., et al. | 2020 | JOURNAL OF CHEMICAL INFORMATION AND MODELING | WoS-id: 000608875100067
Scopus-id: 2-s2.0-85097754285
| 9 | 9 |
| 31 | Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance | Coautor: Velasco-Velázquez M., Camacho-Sandoval R., Jiménez-Uribe A., Tenorio-Calvo A.V., et al. | 2020 | Biotechnology Reports | Scopus-id: 2-s2.0-85083851658
| 0 | 0 |
| 32 | Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes | Coautor: Velasco-Velazquez, Marco, Lopez-Morales, Carlos A., Vazquez-Leyva, Said, Vallejo-Castillo, Luis, et al. | 2019 | JOURNAL OF FOOD SCIENCE | WoS-id: 000460184400008
Scopus-id: 2-s2.0-85061601280
| 20 | 22 |
| 33 | CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon (R)) | Coautor: Velasco-Velazquez, Marco A., Jimenez-Uribe, Alexis P., Valencia-Martinez, Hugo, Carballo-Uicab, Gregorio, et al. | 2019 | JOURNAL OF IMMUNOLOGY RESEARCH | WoS-id: 000465297500001
Scopus-id: 2-s2.0-85066864621
| 21 | 20 |
| 34 | Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug | Coautor: Velasco-Velázquez M.A., Vásquez-Bochm L.X., Velázquez-Paniagua M., Castro-Vázquez S.S., et al. | 2019 | PHARMACOLOGICAL REPORTS | WoS-id: 000468190600023
Scopus-id: 2-s2.0-85064538669
| 28 | 31 |
| 35 | LPA(1) receptor activation induces PKC alpha nuclear translocation in glioblastoma cells | Coautor: Velasco-Velazquez, Marco A., Anahi Valdes-Rives, Silvia, de la Fuente-Granada, Marisol, Gonzalez-Flores, Oscar, et al. | 2019 | INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | WoS-id: 000468720600010
Scopus-id: 2-s2.0-85062702134
| 14 | 14 |
| 36 | Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon (R)) | Coautor: Velasco-Velazquez, Marco, Mellado-Sanchez, Gabriela, Jose Lazaro-Rodriguez, Juan, Avila, Sandra, et al. | 2019 | JOURNAL OF IMMUNOLOGY RESEARCH | WoS-id: 000469233000001
Scopus-id: 2-s2.0-85068496221
| 2 | 2 |
| 37 | Targeting Breast Cancer Stem Cells: A Methodological Perspective | 1ᵉʳ autor: Velasco-Velazquez, Marco A., Velazquez-Qucsada, Nos, Vasquez-Bochm, Luz X., Perez-Tapia, Sonia M. | 2019 | CURRENT STEM CELL RESEARCH & THERAPY | WoS-id: 000474247400003
Scopus-id: 2-s2.0-85069898376
| 4 | 4 |
| 38 | Gpn3 Is Essential for Cell Proliferation of Breast Cancer Cells Independent of Their Malignancy Degree | Coautor: Velasco Velazquez, Marco Antonio, Lara-Chacon, Barbara, Guerrero-Rodriguez, Sandra L., Ramirez-Hernandez, Karla J., et al. | 2019 | TECHNOLOGY IN CANCER RESEARCH & TREATMENT | WoS-id: 000482035900001
Scopus-id: 2-s2.0-85071536784
| 8 | 9 |
| 39 | Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc region | Coautor: Velasco-Velazquez, Marco A., Gonzalez-Gonzalez, Edith, Camacho-Sandoval, Rosa, Jimenez-Uribe, Alexis, et al. | 2019 | JOURNAL OF IMMUNOLOGICAL METHODS | WoS-id: 000483308900011
Scopus-id: 2-s2.0-85056276493
| 6 | 7 |
| 40 | Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract Intended for Batch Release | Coautor: Velasco-Velazquez, Marco, Carballo-Uicab, Gregorio, Linares-Trejo, Jose E., Mellado-Sanchez, Gabriela, et al. | 2019 | Molecules | WoS-id: 000496242300011
Scopus-id: 2-s2.0-85072552906
| 3 | 2 |
| 41 | Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis | Coautor: Velasco-Velazquez, Marco, Vazquez-Leyva, Said, Vallejo-Castillo, Luis, Lopez-Morales, Carlos A., et al. | 2019 | ANALYTICAL CHEMISTRY | WoS-id: 000498280100033
Scopus-id: 2-s2.0-85074880993
| 11 | 13 |
| 42 | Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons | Coautor: Velasco-Velázquez M.A., Mejía-Calvo I., Muñoz-García L., Jiménez-Uribe A., et al. | 2019 | Biotechnology Reports | Scopus-id: 2-s2.0-85064710779
| 0 | 1 |
| 43 | CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion | 2ᵒ autor: Velasco-Velazquez, Marco A., Jiao, Xuanmao, Wang, Min, Li, Zhiping, et al. | 2018 | CANCER RESEARCH | WoS-id: 000429008900007
Scopus-id: 2-s2.0-85047155981
| 97 | 102 |
| 44 | The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer | Coautor: Velasco-Velazquez, Marco A., Hernandez-Esquivel, Miguel A., Perez-Torres, Armando, Romero-Romero, Laura, et al. | 2018 | BIOMEDICINE & PHARMACOTHERAPY | WoS-id: 000429586400108
Scopus-id: 2-s2.0-85043484861
| 14 | 13 |
| 45 | Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFa using flow cytometry detection | Coautor: Velasco-Velázquez M., Camacho-Sandoval R., Sosa-Grande E.N., González-González E., et al. | 2018 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | WoS-id: 000433267700027
Scopus-id: 2-s2.0-85045050940
| 4 | 7 |
| 46 | Design, synthesis and cytotoxic evaluation of quinazoline-2,4,6-triamine and 2,6-diaminoquinazolin-4(3H)-one derivatives | 2ᵒ autor: Velasco-Velázquez M.A., Matus-Meza A.S., Hernández-Luis F. | 2018 | MEDICINAL CHEMISTRY RESEARCH | WoS-id: 000435946100002
Scopus-id: 2-s2.0-85047184155
| 3 | 3 |
| 47 | Synthesis, characterization, cytotoxic and genotoxic evaluation of N6-benzylquinazoline-2,4,6-triamine derivatives | Coautor: Velasco-Velazquez, Marco A., Matus-Meza, Audifas-Salvador, Herrera-Martinez, Mayra, Chavez-Munguia, Bibiana, et al. | 2018 | Abstracts Of Papers Of The American Chemical Society | WoS-id: 000447609102152
| 0 | 0 |
| 48 | Testosterone induces hyporesponsiveness by interfering with IP3 receptors in guinea pig airway smooth muscle | Coautor: Velasco-Velazquez, Marco A., Montano, Luis M., Flores-Soto, Edgar, Reyes-Garcia, Jorge, et al. | 2018 | MOLECULAR AND CELLULAR ENDOCRINOLOGY | WoS-id: 000447981900002
Scopus-id: 2-s2.0-85039552498
| 24 | 26 |
| 49 | Guide for Selection of Relevant Cell Lines During the Evaluation of new Anti-Cancer Compounds | Coautor: Velasco-Velazquez, Marco A., Ruiz-Moreno, Angel J., Torres-Barrera, Patricia, Velazquez-Paniagua, Mireya, et al. | 2018 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | WoS-id: 000454517900001
Scopus-id: 2-s2.0-85060365151
| 1 | 1 |
| 50 | Structure-based virtual screening identifies pranlukast as a CD49f antagonist that reduces stemness in MDA-MB-231 breast cancer cells | 1ᵉʳ autor: Velasco-Velazquez, Marco, Velazquez-Quesada, Ines, Ruiz-Moreno, Angel, Casique-Aguirre, Diana, et al. | 2018 | BRITISH JOURNAL OF CANCER | WoS-id: 000459278300129
| 0 | 0 |
| 51 | Clinical and Experimental Immunomodulation 2016 | Coautor: Velasco-Velazquez, Marco A., Pavon, Lenin, Besedosky, Hugo, Bottasso, Oscar, et al. | 2017 | JOURNAL OF IMMUNOLOGY RESEARCH | WoS-id: 000393978800001
Scopus-id: 2-s2.0-85011908174
| 0 | 0 |
| 52 | Corrigendum: NF-kappaB-inducing kinase regulates stem cell phenotype in breast cancer | Coautor: Velasco-Velazquez M., Vazquez-Santillan K., Melendez-Zajgla J., Jimenez-Hernandez L.E., et al. | 2017 | SCIENTIFIC REPORTS | WoS-id: 000397186800001
Scopus-id: 2-s2.0-85076339293
| 1 | 1 |
| 53 | Selection of presumed CD49f antagonists and their biological evaluation in breast cancer cells | 1ᵉʳ autor: Velasco-Velazquez, M., Velazquez-Quesada, I., Aguirre-Alvarado, C., Guerrero-Rodriguez, S., et al. | 2017 | CANCER RESEARCH | WoS-id: 000397999001156
| 0 | 0 |
| 54 | Extensive preclinical evaluation of an infliximab biosimilar candidate | 1ᵉʳ autor: Velasco-Velazquez, M. A., Salinas-Jazmin, N., Hisaki-Itaya, E., Cobos-Puc, L., et al. | 2017 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | WoS-id: 000401390900005
Scopus-id: 2-s2.0-85014178291
| 7 | 7 |
| 55 | Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK-LKB1 Signaling Axis | Coautor: Velasco-Velazquez, Marco A., Casimiro, Mathew C., Di Sante, Gabriele, Di Rocco, Agnese, et al. | 2017 | CANCER RESEARCH | WoS-id: 000404718400003
Scopus-id: 2-s2.0-85023771902
| 48 | 50 |
| 56 | In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis | Coautor: Velasco-Velázquez M.A., Salinas-Jazmín N., González-González E., Vásquez-Bochm L.X., et al. | 2017 | JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | WoS-id: 000406213900043
Scopus-id: 2-s2.0-85018934168
| 1 | 2 |
| 57 | Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications | Coautor: Velasco-Velazquez, Marco A., Anahi Valdes-Rives, Silvia, Casique-Aguirre, Diana, German-Castelan, Liliana, et al. | 2017 | BIOMED RESEARCH INTERNATIONAL | WoS-id: 000414992700001
Scopus-id: 2-s2.0-85042105092
| 76 | 86 |
| 58 | Producing stem cell-based transplants for future therapeutic purposes | Coautor: Velasco-Velazquez, Marco A., Velasco, Ivan, Kunath, Tilo, Ramos-Mejia, Veronica | 2017 | Stem Cells International | WoS-id: 000418818300001
Scopus-id: 2-s2.0-85042487207
| 0 | 0 |
| 59 | Design, synthesis and in vitro antiproliferative evaluation of quinazoline 2,4,6-triamine and 6-aminoquinazoline-4-(3H)-one derivatives in ovarian cancer skov-3 cell line | Coautor y autor de correspondencia: Velasco-Velazquez, Marco, Matus-Meza, Audifas-Salvador, Hernandez-Luis, Francisco | 2017 | Abstracts Of Papers Of The American Chemical Society | WoS-id: 000429556701461
| 0 | 0 |
| 60 | Design, synthesis and biological evaluation of quinazoline derivatives as cytotoxic molecules of breast cancer triple-negative | Coautor y autor de correspondencia: Velasco-Velazquez, Marco, Matus-Meza, Audifas-Salvador, Hernandez-Luis, Francisco | 2017 | Abstracts Of Papers Of The American Chemical Society | WoS-id: 000430569104300
| 0 | 0 |
| 61 | IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients | Coautor: Antonio Velasco-Velazquez, Marco, Mendieta, Danelia, Luz De la Cruz-Aguilera, Dora, Isabel Barrera-Villalpando, Maria, et al. | 2016 | JOURNAL OF NEUROIMMUNOLOGY | WoS-id: 000368955000004
Scopus-id: 2-s2.0-84955156152
| 109 | 114 |
| 62 | Virtual screening-driven repositioning of etoposide as cd44 antagonist in breast cancer cells | Coautor: Velasco-Velazquez, Marco A., Aguirre-Alvarado, Charmina, Segura-Cabrera, Aldo, Velazquez-Quesada, Ines, et al. | 2016 | Oncotarget | WoS-id: 000377706200060
Scopus-id: 2-s2.0-84966559020
| 14 | 16 |
| 63 | Physicochemical Characteristics of Transferon (TM) Batches | Coautor: Velasco-Velazquez, Marco, Medina-Rivero, Emilio, Vallejo-Castillo, Luis, Vazquez-Leyva, Said, et al. | 2016 | BIOMED RESEARCH INTERNATIONAL | WoS-id: 000380702700001
Scopus-id: 2-s2.0-84982857123
| 11 | 12 |
| 64 | Early Differentiation of Human CD11c(+)NK Cells with gamma delta T Cell Activation Properties Is Promoted by Dialyzable Leukocyte Extracts | Coautor: Antonio Velasco-Velazquez, Marco, Ramirez-Ramirez, Dalia, Vadillo, Eduardo, Andrea Arriaga-Pizano, Lourdes, et al. | 2016 | JOURNAL OF IMMUNOLOGY RESEARCH | WoS-id: 000387402900001
Scopus-id: 2-s2.0-84994416098
| 13 | 14 |
| 65 | NF-kappaB-inducing kinase regulates stem cell phenotype in breast cancer | Coautor: Velasco-Velazquez, Marco, Vazquez-Santillan, Karla, Melendez-Zajgla, Jorge, Enrique Jimenez-Hernandez, Luis, et al. | 2016 | SCIENTIFIC REPORTS | WoS-id: 000388788300001
Scopus-id: 2-s2.0-84997386090
| 59 | 60 |
| 66 | Herpes Murine Model as a Biological Assay to Test Dialyzable Leukocyte Extracts Activity | Coautor: Velasco-Velazquez M.A., Salinas-Jazmin N., Estrada-Parra S., Becerril-Garcia M.A., et al. | 2015 | JOURNAL OF IMMUNOLOGY RESEARCH | WoS-id: 000353776000001
Scopus-id: 2-s2.0-84929378004
| 15 | 15 |
| 67 | Immunomodulatory Effects Mediated by Serotonin | Coautor: Velasco-Velázquez M.A., Arreola R., Becerril-Villanueva E., Cruz-Fuentes C., et al. | 2015 | JOURNAL OF IMMUNOLOGY RESEARCH | WoS-id: 000353776900001
Scopus-id: 2-s2.0-84929380005
| 150 | 158 |
| 68 | Clinical and experimental immunomodulation 2014 | Coautor: Velasco-Velázquez M.A., Pavón L., Bottasso O., Besedosky H., et al. | 2015 | JOURNAL OF IMMUNOLOGY RESEARCH | WoS-id: 000354303000001
Scopus-id: 2-s2.0-84929376512
| 1 | 1 |
| 69 | Swine Dialyzable Spleen Extract as Antiviral Prophylaxis | Coautor: Velasco-Velázquez M., Merchand-Reyes G., Pavón L., Pérez-Sánchez G., et al. | 2015 | JOURNAL OF MEDICINAL FOOD | WoS-id: 000363940500008
Scopus-id: 2-s2.0-84946041684
| 2 | 2 |
| 70 | Expression and hormonal regulation of membrane progesterone receptors in human astrocytoma cells | Coautor: VelascoVelazquez, MA, ValadezCosmes, P, GermanCastelan, L, GonzalezArenas, A, et al. | 2015 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | WoS-id: 000364251200021
Scopus-id: 2-s2.0-84940529037
| 25 | 24 |
| 71 | Antimetastatic effect of a Dializable Leucocyte Extract in a murine model of prostate cancer | Coautor: VelascoVelazquez, MA, HernandezEsquivel, MA, PerezTapia, SM, Pestell, RG | 2015 | CANCER RESEARCH | WoS-id: 000371597105374
| 0 | 0 |
| 72 | Biological activity of dialyzable leukocyte extracts in a mouse cutaneous herpes model. | Coautor: Velasco-Velazquez, Marco, Perez-Tapia, Sonia, Salinas-Jazmin, Nohemi, Estrada-Parra, Sergio, et al. | 2014 | JOURNAL OF IMMUNOLOGY | WoS-id: 000209765000069
| 0 | 0 |
| 73 | Batch-to-batch reproducibility of Transferon? | Coautor: Velasco-Velázquez M., Medina-Rivero E., Merchand-Reyes G., Pavón L., et al. | 2014 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | WoS-id: 000329532800039
Scopus-id: 2-s2.0-84885070260
| 29 | 31 |
| 74 | Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: Past and present | 2ᵒ autor: Velasco-Velázquez M., Casimiro M.C., Aguirre-Alvarado C., Pestell R.G. | 2014 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | WoS-id: 000331730500002
Scopus-id: 2-s2.0-84894211810
| 136 | 146 |
| 75 | A Flow Cytometry-Based Assay for the Evaluation of Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in Cancer Cells | Coautor y autor de correspondencia: Velasco-Velázquez M.A., Salinas-Jazmín N., Hisaki-Itaya E. | 2014 | Methods in Molecular Biology | WoS-id: 000338510500017
Scopus-id: 2-s2.0-84927154840
| 11 | 12 |
| 76 | The potential to target CCL5/CCR5 in breast cancer | 1ᵉʳ autor: Velasco-Velázquez M., Xolalpa W., Pestell R.G. | 2014 | EXPERT OPINION ON THERAPEUTIC TARGETS | WoS-id: 000343926100004
Scopus-id: 2-s2.0-84911476229
| 86 | 87 |
| 77 | CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines | Coautor: Velasco-Velazquez M., Sicoli D., Jiao X., Ju X., et al. | 2014 | CANCER RESEARCH | WoS-id: 000346362400034
Scopus-id: 2-s2.0-84918564403
| 61 | 62 |
| 78 | The CCL5/CCR5 axis promotes metastasis in basal breast cancer | 1ᵉʳ autor: Velasco-Velázquez M., Pestell R.G. | 2013 | OncoImmunology | WoS-id: 000322566200010
Scopus-id: 2-s2.0-84886944330
| 62 | 50 |
| 79 | Zosteriform spread of Herpes simplex virus 1 as a model to study the role of leukocyte subpopulations in the mortality induced during acute infection | Coautor: Velasco-Velazquez, M, Salinas, N, Becerril-Garcia, M, Hisaki-Itaya, E, et al. | 2013 | JOURNAL OF IMMUNOLOGY | WoS-id: 000322987105187
| 0 | 0 |
| 80 | Chronic deep brain stimulation of the hypothalamic nucleus in Wistar rats alters circulatory levels of corticosterone and proinflammatory cytokines | Coautor: Velasco-Velázquez M.A., Calleja-Castillo J.M., De La Cruz-Aguilera D.L., Manjarrez J., et al. | 2013 | CLINICAL & DEVELOPMENTAL IMMUNOLOGY | WoS-id: 000326620300001
Scopus-id: 2-s2.0-84887420908
| 19 | 17 |
| 81 | Randomized, double-blind trial of topical methylprednisolone combined with oral dialyzable leukocyte extract in patients with moderate atopic dermatitis | Coautor: Velazquez, MV, Carreon, JG, Cortes, ER, Bahena, MT, et al. | 2013 | Immunology | WoS-id: 000327487700381
| 0 | 0 |
| 82 | Clinical and experimental immunomodulation | Coautor: Velasco M., Pavón L., Besedosky H., Bottasso O., et al. | 2013 | CLINICAL & DEVELOPMENTAL IMMUNOLOGY | WoS-id: 000328973400001
Scopus-id: 2-s2.0-84893762480
| 0 | 1 |
| 83 | Breast cancer stem cells | 1ᵉʳ autor: Velasco-Velázquez M.A., Homsi N., De La Fuente M., Pestell R.G. | 2012 | INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | WoS-id: 000302516300001
Scopus-id: 2-s2.0-84857919004
| 125 | 139 |
| 84 | CCR5 antagonist blocks metastasis of basal breast cancer cells | 1ᵉʳ autor: Velasco-Velázquez M., Jiao X., De La Fuente M., Pestell T.G., et al. | 2012 | CANCER RESEARCH | WoS-id: 000307354100015
Scopus-id: 2-s2.0-84864863792
| 223 | 233 |
| 85 | Examining the role of cyclin D1 in breast cancer | 1ᵉʳ autor: Velasco-Velázquez M.A., Li Z., Casimiro M., Loro E., et al. | 2011 | FUTURE ONCOL | WoS-id: 000292440200011
Scopus-id: 2-s2.0-79959448584
| 54 | 68 |
| 86 | The Role of Breast Cancer Stem Cells in Metastasis and Therapeutic Implications | 1ᵉʳ autor: Velasco-Velázquez M.A., Popov V.M., Lisanti M.P., Pestell R.G. | 2011 | AMERICAN JOURNAL OF PATHOLOGY | WoS-id: 000298307100001
Scopus-id: 2-s2.0-80052479916
| 126 | 145 |
| 87 | Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model | Coautor: Velasco-Velázquez M.A., Salinas-Jazmín N., De La Fuente M., Jaimez R., et al. | 2010 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | WoS-id: 000274655500014
Scopus-id: 2-s2.0-77649180895
| 12 | 15 |
| 88 | Cancer stem cells and the cell cycle: targeting the drive behind breast cancer | 1ᵉʳ autor: Velasco-Velázquez M.A., Yu Z., Jiao X., Pestell R.G. | 2009 | EXPERT REVIEW OF ANTICANCER THERAPY | WoS-id: 000264493600002
Scopus-id: 2-s2.0-65749098800
| 14 | 15 |
| 89 | Role of cancer stem cells in the therapeutic resistance of breast tumors [Papel de las células madre oncogénicas: En la resistencia terapéutica de tumores de mama] | 1ᵉʳ autor: Velasco Velázquez M.A., Granada M.D.L.F. | 2009 | Revista Venezolana de Oncologia | Scopus-id: 2-s2.0-77949888553
| 0 | 0 |
| 90 | Reduced paxillin expression contributes to the antimetastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells | 1ᵉʳ autor: Velasco-Velazquez, MA, Salinas-Jazmin, N, Mendoza-Patino, N, Mandoki, JJ | 2008 | CANCER CELL INTERNATIONAL | WoS-id: 000208405200008
Scopus-id: 2-s2.0-45749148244
| 26 | 32 |
| 91 | Accumulation of HSP25 and HSP70 partially protects LLC-PK1 cells against the nephrotoxic drug acetaminophen | 1ᵉʳ autor: Velasco-Velazquez, M, Hernandez, M, Parcero, K | 2008 | FEBS JOURNAL | WoS-id: 000256633300633
| 0 | 0 |
| 92 | GABA effects during neuronal differentiation of stem cells | 2ᵒ autor: Velasco-Velazquez, MA, Salazar, P, Velasco, I | 2008 | NEUROCHEMICAL RESEARCH | WoS-id: 000257237900017
Scopus-id: 2-s2.0-46249100443
| 18 | 21 |
| 93 | Aged garlic extract induces proliferation and ameliorates gentamicin-induced toxicity in LLC-PK1 cells | 1ᵉʳ autor: Velasco-Velázquez M.A., Maldonado P.D., Barrera D., Torres V., et al. | 2006 | PHYTOTHERAPY RESEARCH | WoS-id: 000234905300016
Scopus-id: 2-s2.0-31644431634
| 12 | 13 |
| 94 | Hormone multifunctionalities: A theory of endocrine signaling, command and control | Coautor: Velasco-Velázquez M.A., Mandoki J.J., Mendoza-Patiño N., Molina-Guarneros J.A., et al. | 2004 | PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY | WoS-id: 000224152300001
Scopus-id: 2-s2.0-4143123568
| 5 | 6 |
| 95 | Influence of serum-free medium on the expression of glutamate transporters and the susceptibility to glutamate toxicity in cultured cortical neurons | 2ᵒ autor: Velasco-Velázquez M.A., Velasco I., Salazar P., Lajud N., et al. | 2003 | JOURNAL OF NEUROSCIENCE RESEARCH | WoS-id: 000181327400008
Scopus-id: 2-s2.0-0344406820
| 19 | 21 |
| 96 | Macrophage - Mycobacterium tuberculosis interactions: Role of complement receptor 3 | 1ᵉʳ autor: Velasco-Velázquez M.A., Barrera D., González-Arenas A., Rosales C., et al. | 2003 | MICROBIAL PATHOGENESIS | WoS-id: 000185126600004
Scopus-id: 2-s2.0-0043123255
| 71 | 73 |
| 97 | 4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16-F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility | 1ᵉʳ autor: Velasco-Velázquez M.A., Agramonte-Hevia J., Barrera D., Jiménez-Orozco A., et al. | 2003 | CANCER LETTERS | WoS-id: 000186363700007
Scopus-id: 2-s2.0-10744229093
| 72 | 88 |
| 98 | Gram-negative bacteria and phagocytic cell interaction mediated by complement receptor 3 | Coautor: Velasco-Velázquez M., Agramonte-Hevia J., González-Arenas A., Barrera D. | 2002 | FEMS IMMUNOL MED MIC | WoS-id: 000179485800002
Scopus-id: 2-s2.0-0037073562
| 47 | 47 |
| 99 | Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin | Coautor: Velasco-Velázquez M.A., Jiménez-Orozco F.A., López-González J.S., Nieto-Rodriguez A., et al. | 2001 | LUNG CANCER | Scopus-id: 2-s2.0-0034776555
| 0 | 63 |
| 100 | Integrins and integrin-associated molecules: Targets for the development of antimetastasic therapies [Integrinas y moléculas asociadas a integrinas: Blancos para el desarrollo de terapias antimetastásicas] | 1ᵉʳ autor: Velasco-Velázquez M.A., Molina-Guarneros J.A., Mendoza-Patiño N., López G J.S., et al. | 1999 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000082026800006
Scopus-id: 2-s2.0-0142073129
| 5 | 6 |
| 101 | Cell cycle and its abnormalities in lung cancer [Ciclo celular y sus anormalidades en el cancer de pulmon] | Coautor: Velasco-Velazquez M.A., Jimenez-Orozco F.A., Sullivan Lopez J., Aguilar Cazares D., et al. | 1999 | Revista Del Instituto Nacional De Enfermedades Respiratorias | Scopus-id: 2-s2.0-0032732376
| 0 | 0 |
ID's SCOPUS 
ORCID's 